Cacu y vph

Calcium channel blockers for inhibiting preterm labour (Review)
King JF, Flenady VJ, Papatsonis DNM, Dekker GA, Carbonne B

This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2007, Issue 4 http://www.thecochranelibrary.com

Calcium channel blockers for inhibiting preterm labour (Review) Copyright © 2007 TheCochrane Collaboration. Published by John Wiley & Sons, Ltd

1

TABLE OF CONTENTS ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW . . . . . . . . . . . . . . . . . . SEARCH METHODS FOR IDENTIFICATION OF STUDIES . . . . . . . . . . . . . . . . . . . METHODS OF THE REVIEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . DESCRIPTION OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . METHODOLOGICAL QUALITY . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . POTENTIAL CONFLICT OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . ACKNOWLEDGEMENTS . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Characteristics of included studies . . . . . . . . . . . . . . . . . . . . . . . . .. . . . Characteristics of excluded studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Comparison 01. Any calcium channel blocker compared with any other tocolytic agent . . . . . . . . . . Comparison 02. Any dihydropyridine calcium channel blocker compared with any betamimetic agent . . . . . INDEXTERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . COVER SHEET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . GRAPHS AND OTHER TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Analysis 01.01. Comparison 01 Any calcium channel blocker compared with any other tocolytic agent, Outcome 01 Birth prior to 37 weeks gestation . . . . .. . . . . . . . . . . . . . . . . . . . . . Analysis 01.02. Comparison 01 Any calcium channel blocker compared with any other tocolytic agent, Outcome 02 Birth prior to 34 weeks gestation . . . . . . . . . . . . . . . . . . . . . . . . . . . Analysis 01.03. Comparison 01 Any calcium channel blocker compared with any other tocolytic agent, Outcome 03 Birth within seven days of treatment . . . . .. . . . . . . . . . . . . . . . . . . . . Analysis 01.04. Comparison 01 Any calcium channel blocker compared with any other tocolytic agent, Outcome 04 Birth within 48 hours of treatment . . . . . . . . . . . . . . . . . . . . . . . . . . Analysis 01.05. Comparison 01 Any calcium channel blocker compared with any other tocolytic agent, Outcome 05 Pregnancy prolongation (days) . . . . . . . . . . .. . . . . . . . . . . . . . . . . Analysis 01.06. Comparison 01 Any calcium channel blocker compared with any other tocolytic agent, Outcome 06 Maternal adverse drug reaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . Analysis 01.07. Comparison 01 Any calcium channel blocker compared with any other tocolytic agent, Outcome 07 Maternal drug reaction requiring cessation of treatment...